Generic Drugs

Jul 20, 2006
ePT--the Electronic Newsletter of Pharmaceutical Technology
In a move to strengthen its position in Western generic drug markets, Ranbaxy Laboratories Ltd. (Gurgaon, Haryana, India) acquired the Mundogen generic drug business of GlaxoSmithKline (GSK, London, England) in Spain, through Ranbaxy's Spanish subsidiary, Laboratorios Ranbaxy S.L.
Jul 06, 2006
ePT--the Electronic Newsletter of Pharmaceutical Technology
By Pharmaceutical Technology Editors
Does the competition from authorized generics really help lower drug prices and boost healthcare savings?
Jun 29, 2006
ePT--the Electronic Newsletter of Pharmaceutical Technology
Pfizer, Inc. (New York, NY) reports the United Kingdom's Court of Appeal has upheld the exclusivity of the main patent covering atorvastatin, the active ingredient in "Lipitor."
Jun 29, 2006
ePT--the Electronic Newsletter of Pharmaceutical Technology
The US Food and Drug Administration (Rockville, MD) approved the first generic versions of "Zocor" (simvastatin), the anticholesterol drug by Merck & Co., Inc. (Whitehouse Station, NJ).
Jun 29, 2006
ePT--the Electronic Newsletter of Pharmaceutical Technology
By Pharmaceutical Technology Editors
Last week, the Generic Pharmaceutical Association (GPhA Arlington, VA) praised a proposal by the Senate Agricultural Appropriations Subcommittee that, if approved, would provide $10 million in additional funding for the US Food and Drug Administration?s (Rockville, MD) Office of Generic Drugs.
Apr 20, 2006
ePT--the Electronic Newsletter of Pharmaceutical Technology
Sandoz (Holzkirchen, Germany), the generics division of Novartis (Basel, Switzerland) received European marketing authorization for its recombinant human growth hormone, ?Omnitrope? (somatropin), making it the first biogeneric product approved under the biosimilar pathway of the European Commission.
Apr 06, 2006
ePT--the Electronic Newsletter of Pharmaceutical Technology
FTC Plans to Study Competitive Impacts of Authorized Generic Drugs
Mar 24, 2006
ePT--the Electronic Newsletter of Pharmaceutical Technology
BMS, Sanofi-Aventis Settle Over Generic Plavix
Mar 09, 2006
ePT--the Electronic Newsletter of Pharmaceutical Technology
GSK Loses Bid to Block Generic "Flonase"
Nov 23, 2005
ePT--the Electronic Newsletter of Pharmaceutical Technology
By Pharmaceutical Technology Editors
GSK Study Questions Bioequivalency of Generic Cold Sore Creams
native1_300x100
lorem ipsum